DFIM
JAZZ icon

Detwiler Fenton Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Detwiler Fenton Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,200
Closed -$386K – 123
2013
Q3 		$386K Buy
+4,200
New +$339K 0.34% 68

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.62B AUM 39.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Detwiler Fenton Investment Management's JAZZ Position: Q4 2013 in Review

Detwiler Fenton Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2013, closing a stake of 4,200 shares — an estimated $386K sold.

Detwiler Fenton Investment Management first reported a position in JAZZ in Q3 2013 and held it in 1 quarter. The position peaked at $386K in Q3 2013. 280 funds tracked by Wall St. Rank hold JAZZ as of Q4 2013.

  • Detwiler Fenton Investment Management reported no remaining Jazz Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Detwiler Fenton Investment Management sold 4,200 Jazz Pharmaceuticals shares in Q4 2013, an estimated $386K.
  • Detwiler Fenton Investment Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Detwiler Fenton Investment Management's Jazz Pharmaceuticals position peaked at $386K in Q3 2013.
  • 280 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2013.

Based on Detwiler Fenton Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.